KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Supernus Pharmaceuticals (SUPN) Tax Provisions (2016 - 2025)

Historic Tax Provisions for Supernus Pharmaceuticals (SUPN) over the last 12 years, with Q3 2025 value amounting to -$12.8 million.

  • Supernus Pharmaceuticals' Tax Provisions fell 29914.68% to -$12.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.7 million, marking a year-over-year decrease of 11300.47%. This contributed to the annual value of $24.0 million for FY2024, which is 155209.91% up from last year.
  • Per Supernus Pharmaceuticals' latest filing, its Tax Provisions stood at -$12.8 million for Q3 2025, which was down 29914.68% from -$5.8 million recorded in Q2 2025.
  • Over the past 5 years, Supernus Pharmaceuticals' Tax Provisions peaked at $25.9 million during Q3 2023, and registered a low of -$16.3 million during Q2 2023.
  • For the 5-year period, Supernus Pharmaceuticals' Tax Provisions averaged around $1.7 million, with its median value being $3.5 million (2022).
  • Per our database at Business Quant, Supernus Pharmaceuticals' Tax Provisions crashed by 56571.43% in 2023 and then skyrocketed by 604864.86% in 2024.
  • Quarter analysis of 5 years shows Supernus Pharmaceuticals' Tax Provisions stood at -$391000.0 in 2021, then soared by 2570.33% to $9.7 million in 2022, then plummeted by 101.92% to -$185000.0 in 2023, then soared by 6048.65% to $11.0 million in 2024, then crashed by 216.65% to -$12.8 million in 2025.
  • Its Tax Provisions was -$12.8 million in Q3 2025, compared to -$5.8 million in Q2 2025 and $6.0 million in Q1 2025.